prostratin has been researched along with ingenol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darnell, GA; Gardner, J; Harrich, D; Suhrbier, A; Warrilow, D | 1 |
| Li, X; Lu, H; Lu, P; Ma, Z; Qu, X; Shen, Y; Wang, P; Wu, H; Xu, J; Zeng, H; Zhu, H; Zhu, X; Zhu, Y | 1 |
| Andersen, RJ; Ntie-Kang, F; Tietjen, I | 1 |
| Benner, NL; Chun, TW; Dimapasoc, M; Keenan, KN; Marsden, MD; Sloane, JL; Soliman, MSA; Wender, PA; Wu, X; Zack, JA; Zang, X | 1 |
1 review(s) available for prostratin and ingenol
| Article | Year |
|---|---|
Natural product-derived compounds in HIV suppression, remission, and eradication strategies.
Topics: Anti-HIV Agents; Biological Products; Bryostatins; Depsipeptides; Disease Reservoirs; Diterpenes; Drug Discovery; Gene Products, tat; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Phorbol Esters; rev Gene Products, Human Immunodeficiency Virus; Virus Latency; Vorinostat | 2018 |
3 other study(ies) available for prostratin and ingenol
| Article | Year |
|---|---|
HIV type 1 inhibition by protein kinase C modulatory compounds.
Topics: CD4 Antigens; Cells, Cultured; Diterpenes; Down-Regulation; Gene Expression Regulation; HeLa Cells; HIV Infections; HIV-1; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Phorbol Esters; Protein Kinase C; Protein Kinase Inhibitors; Receptors, Chemokine; Tetradecanoylphorbol Acetate; Virus Activation; Virus Latency | 2006 |
Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui.
Topics: Anti-HIV Agents; Cell Death; Cell Survival; Cells, Cultured; Diterpenes; Drug Synergism; Drug Therapy, Combination; Euphorbia; HIV Infections; HIV-1; Humans; NF-kappa B; Phorbol Esters; Positive Transcriptional Elongation Factor B; Protein Kinase C; Signal Transduction; T-Lymphocytes; Transcriptional Activation; Virus Activation; Virus Latency | 2017 |
Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window.
Topics: Animals; Anti-HIV Agents; Bryostatins; Cell Line, Tumor; Cells, Cultured; Diterpenes; HIV Infections; HIV-1; Humans; Mice; Mice, Inbred C57BL; Phorbol Esters; Prodrugs; Protein Kinase C; Virus Latency | 2020 |